Project Grant TL1DK151273
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University a cooperative agreement for $195,437 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds the Connecticut Kidney, Urology, and Hematology Research Training (CKRT) Program, a TL1 training initiative that develops predoctoral and postdoctoral scientists for research careers in nephrology, urology, and classical hematology at...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $839,770 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents. The award is a Project Grant with a period of performance extending through February 28, 2031, and work is performed in New Haven, Connecticut. The program promotes extramural basic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $623,607 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on August 1, 2026. The award funds research examining how impaired double-stranded DNA repair induces podocyte senescence and contributes to chronic kidney disease progression. The project integrates advanced genetic models, including podocyte-specific SETD1A knockout mice that develop focal segmental...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $126,000 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify vascular biomarkers and tissue signatures that predict cardiovascular risk in kidney transplant recipients. The project investigates whether early vascular biomarker trajectories and tissue expression patterns identify kidney transplant recipients at highest risk of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $249,999 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate transcriptional dysregulation mechanisms in SF3B1-mutant myelodysplastic syndromes. The research focuses on defining the role of HTATSF1, a protein involved in both splicing and transcription, in transcriptional dysregulation in splicing-factor-mutant myelodysplastic...
- Federal Grant Award Summary Yale University received a $3.23 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. The award supports investigator-initiated biomedical research focused on understanding the role of neutrophils in the pathogenesis of cholangiopathies—a group of bile duct diseases...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Trustees of Indiana University $145,648 on June 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support predoctoral research training and career development for a doctoral candidate investigating fibroblast activation protein (FAP) in chronic kidney disease progression. The award funds research into the role of FAP in renal fibrosis, a pathological...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Veterans Medical Research Foundation of San Diego $383,098 on September 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The recipient will conduct research into kidney tubule dysfunction in APOL1-associated chronic kidney disease, with focus on developing and validating tubular biomarkers that capture kidney functions—nutrient reabsorption and toxin...
- Federal Grant Award Summary Yale University received a $133,333 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for August 31, 2026. The award funds research aimed at correcting the myeloid bias of aged hematopoietic stem and progenitor cells (HSPCs) by preventing linker histone turnover,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Tulane University $1,226,298 on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate epigenetic control of nephron progenitor cell lifespan in mice and humans. The research addresses the cessation of nephrogenesis at birth, which eliminates the opportunity to generate new nephrons following congenital or acquired loss of renal mass. The project...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $488,592 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a TL1 training program for predoctoral students, postdoctoral physician-scientists, and postdoctoral PhD scientists pursuing research-focused careers in adult and pediatric nephrologic, urologic, and hematologic health and disease. The program identifies and recruits trainees of exceptional promise through broad outreach to mentors and trainees across the participating research community, with annual requests for applications distributed to all departments at relevant schools and to national societies and professional organizations. Both postdoctoral and predoctoral applicants are ranked using a study section format based on quality and scientific merit. Trainees are recruited without regard to race, sex, or ethnicity and are open to all meritorious candidates. The program strives to recruit trainees from both participating institutions—Yale and the University of Connecticut—with support for research interests spanning kidney, urologic, and hematologic sciences. All appointed trainees receive a primary research mentor who has completed mentor training and is approved by the administrative core. The award funds work performed in New Haven, Connecticut, with a period of performance extending from September 1, 2026, through June 30, 2031. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $488.6k | 7/30/26 |